KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Microbiology and Infectious Diseases / 2016 / Cilt: 6 - Sayı: 3

Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia

Mubashir Ahmad Khan
AFTAB FAİZ
Sayfa
121–127
Yayın Tarihi
2016-09-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

J Microbiol Infect Dis 2016;6(3): 121-127

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Carbapenemase producing Klebsiella pneumoniae is emerging as an important pathogen worldwide which has alarming clinical threat with serious effects on patients’ outcome.
📊
Temel Bulgular & Veri:Methods: A prospective study was performed on 260 clinical isolates of K. pneumoniae collected from five different hospitals of Makkah, Saudi Arabia from January to July 2015.
💡
Sonuç & Katkı:J Microbiol Infect Dis 2016;6(3): 121-127
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Klebsiella pneumoniae · carbapenemase · drug resistance

Abstract

Objective: Carbapenemase producing Klebsiella pneumoniae is emerging as an important pathogen worldwide which has alarming clinical threat with serious effects on patients’ outcome. The aim of our study is to determine prevalence of carbapenemase producing K. pneumoniae and its antibiotic susceptibility pattern in tertiary care hospitals. Methods: A prospective study was performed on 260 clinical isolates of K. pneumoniae collected from five different hospitals of Makkah, Saudi Arabia from January to July 2015. All clinical isolates were confirmed as K. pneumoniae using Vitek 2 system. These isolates were then screened for potential carbapenemase producers by determining reduced susceptibility to carbapenems using representative antibiotic disks of third generation cephalosporins and carbapenems in the disk diffusion test following guidelines of Clinical and Laboratory Standards Institute. Minimum inhibitory concentration of isolates found positive in screening test were determined for cephalosporins, carbapenems, aminoglycosides and tigecycline and colistin using Vitek-2 system. Modified Hodge test was performed to detect carbapenemase production on the isolates suspected for carbapenemase production. Results: Out of 260 K. pneumoniae isolates, 31 (11.9%) have shown 100% resistance to all cephalosporins. Of 31 K. pneumoniae isolates, 15 (48.4%) were found positive for carbapenemase. All carbapenem resistant isolates were sensitive to colistin and tigecycline. However, these isolates have shown resistance to amikacin (41.9%) and gentamicin (51.6%), respectively. Conclusion: This is the first report from Makkah reporting carbapenamse producing K.pneumoniae. Of 12% potential carbapenemase producing K.pneumoniae, 48.4% were found positive for carbapenemase production. Molecular characterization of these strains will help to determine the type of carbapenemase prevalent in this area. J Microbiol Infect Dis 2016;6(3): 121-127

🔖

Bu Makaleye Atıf Yap

Khan, M. A., FAİZ, A. (2016). Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia. Journal of Microbiology and Infectious Diseases, Cilt: 6 - Sayı: 3, 121–127. https://ajindex.com/articles/48246

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236
  2. World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: WHO Press 2014: 17-19
  3. Bush K, Jacoby GA. Updated Functional Classification of β-lactamases. Antimicrob Agents Chemother 2010; 54: 969- 976
  4. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-1798
  5. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamases, KPC-1, from a carbapenem resistant strains of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-1161
  6. Mammina C, Palma DM, Bonura C, et al. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol 2010; 48:1506-1507
  7. Pesesky MW, Hussain T, Wallace M, et al. KPC and NDM-1 Genes in Related Enterobacteriaceae Strains and Plasmids from Pakistan and the United States. Emerg Infect Dis 2015; 21:1034-1037
  8. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25:682–707
  9. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 253:5046–54
  10. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602
  11. Nordmann P, Poirel L, Walsh TR. The emerging NDM carbapenemases. Trends Microbiol 2011; 19:588-595
  12. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in gram-negative bacteria. Bio Med Res Int 2014; 1-12
  13. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA- 48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012; 18: E144–E148
  14. El-Herte RI, Araj GF, Matar GM, et al. Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon (case report). J Infect Dev Ctries 2012; 6:457-61. 15.